Literature DB >> 23824206

Antipsychotic medication during the critical period following remission from first-episode psychosis: less is more.

Patrick McGorry1, Mario Alvarez-Jimenez, Eoin Killackey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23824206     DOI： 10.1001/jamapsychiatry.2013.264

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  13 in total

Review 1.  Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.

Authors:  M Alvarez-Jimenez; B O'Donoghue; A Thompson; J F Gleeson; S Bendall; C Gonzalez-Blanch; E Killackey; L Wunderink; P D McGorry
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

2.  Improving outcomes of first-episode psychosis: an overview.

Authors:  Paolo Fusar-Poli; Patrick D McGorry; John M Kane
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

3.  Attempting to stop antipsychotic medication: success, supports, and efforts to cope.

Authors:  Miriam Larsen-Barr; Fred Seymour; John Read; Kerry Gibson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-04-23       Impact factor: 4.328

Review 4.  Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.

Authors:  Chen-Chung Liu; Hiroyoshi Takeuchi
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

5.  A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.

Authors:  Martin Harrow; Thomas H Jobe; Robert N Faull; Jie Yang
Journal:  Psychiatry Res       Date:  2017-06-22       Impact factor: 3.222

Review 6.  Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.

Authors:  Nancy Sohler; Ben G Adams; David M Barnes; Gregory H Cohen; Seth J Prins; Sharon Schwartz
Journal:  Am J Orthopsychiatry       Date:  2015-12-14

7.  The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia.

Authors:  Kenneth L Subotnik; Joseph Ventura; Denise Gretchen-Doorly; Gerhard S Hellemann; Elisha R Agee; Laurie R Casaus; John S Luo; Kathleen F Villa; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2014-08-06       Impact factor: 4.939

8.  A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse.

Authors:  Mark Abie Horowitz; Sameer Jauhar; Sridhar Natesan; Robin M Murray; David Taylor
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 7.348

9.  Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia.

Authors:  Michael Davidson; Jay Saoud; Corinne Staner; Nadine Noel; Sandra Werner; Elisabeth Luthringer; David Walling; Mark Weiser; Philip D Harvey; Gregory P Strauss; Remy Luthringer
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

10.  Study protocol for a systematic review of evidence for lifestyle interventions targeting smoking, sleep, alcohol/other drug use, physical activity, and healthy diet in people with bipolar disorder.

Authors:  Frances J Kay-Lambkin; Louise Thornton; Julia M Lappin; Tanya Hanstock; Louisa Sylvia; Felice Jacka; Amanda L Baker; Michal Berk; Phillip B Mitchell; Robin Callister; Naomi Rogers; Stephanie Webster; Simon Dennis; Christopher Oldmeadow; Andrew MacKinnon; Christopher Doran; Alyna Turner; Sally Hunt
Journal:  Syst Rev       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.